Cologne-based biotech start-up Disco Pharmaceuticals is taking a new approach to cancer therapy: using innovative ...

Personalised cancer therapies have long been considered one of medicine’s most promising frontiers. Recent clinical results from Merck and Moderna involving mRNA-based approaches have added fresh ...

Every early-stage life sciences asset is heading towards the most regulated industry in the world. The process used to evaluate these as- sets, however, is rarely held to any comparable standard.

The landscape for radiopharmaceutical therapies in oncology is evolving rapidly, propelled by early commercial successes and ...

ESMT Berlin und KfW Capital haben ein Leadership-Programm entwickelt, das Fondsmanager sowie Kapitalgeber auf ihre Aufgaben ...

Im Münchener WERK1 wurden am 28. Oktober 2026 die diesjährigen Preisträger des Gründerpreises der Stadtsparkasse München ...

Companisto erzielt 45 Mio. EUR Investitionsvolumen 2025 und mehr als doppelt so hohes EBIT im ersten Quartal 2026.

DEBRA Research has invested in Topadur Pharma to support the preclinical development of small-molecule therapies for ...

Christian Lindner investiert in QuoIntelligence, das als Europas vielversprechendstes Cybersicherheits-Start-up 2026 ...

Business Angels Tag 2026: Vom 5. bis 7. November treffen sich 400 Investoren und 34 Start-ups zur Frühphasenfinanzierung in ...

Germany was about to start. The legal foundation had been laid, and the relevant law was on its way to taking effect. – particularly in and regarding the life sciences.stock.adobe.com, bernardbodo ...

Rhineland-Palatinate fostered its position as a leading biotech location. The Life Science Zentrum Mainz (LZM) connects science, start-ups, and industry through its business units BioVation RLP and ...